Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
PSCA-targeting NANO:BICs increased cellular uptake by a factor of 3.63 in PSCA-positive bladder cancer cells, leading to potent TLR9 pathway activation. This 438.2 KB document by Max Iltzsche, uploaded to figshare in April 2026, contains the methods and results from a study on targeted nanoparticle immunotherapy. The findings highlight the potential for reinvigorating anti-tumor immune responses in bladder cancer and other PSCA-expressing malignancies.
The primary data file is in DOCX format, which may require specific software for viewing and data extraction.